North Americans join to fight health fraud
This article was originally published in Clinica
Canada, Mexico and the US have signed an agreement to combat jointly the fraudulent marketing and sale of health-related products, devices and services. Health Canada, the Secretaria de Salud of Mexico, the US FDA and the US Federal Trade Commission (FTC) have agreed to act together to reduce the problem on the borders between the three countries.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.